Helping in the battle against brain cancer
Guest User
A Staffordshire-based manufacturer of bespoke medical devices is playing its part in the earlier diagnosis of brain cancer.
Medical Moulded Products (MMP) has been awarded a contract to develop single-cavity slides at its Burton-on-Trent headquarters, which houses five separate cleanrooms for the manufacture of medical-grade products for the dental and medical sectors.
The contract, awarded by Glasgow-based DxCover Ltd which works in partnership with the world renowned Strathclyde University, will see the firm produce 15,000 cleanroom-manufactured slides that will be used for the detection of cancer cells via blood serum droplets.
The ground-breaking technology, used by DxCover, will use infrared light and proprietary algorithms to analyse patient blood serum samples and detect the presence or absence of disease.
The medical-grade plastic slides, will play an instrumental part of the process, allowing doctors to diagnose cancer more quickly.
MMP specifically appealed to the company because of its ability to work with partners from concept to end design.
Peter Lucas, co-director of Medical Moulded Products said: “Our unique offering is in the ability to create products that meet all technical and regulatory requirements and to be able to adapt designs that enable our clients to find the perfect solution.
“Initially we worked on a low volume of slides for DxCover which, after a couple of alterations, were adapted by our team and specialist on-site equipment to help revolutionise the detection of brain cancer.”
Dr Mark Hegarty, CEO and Co-founder of DxCover Ltd, said “It’s been a pleasure to work with the team at Medical Moulded Products. I’m delighted to see that MMP are growing and can highly recommend them for their thoroughly professional service, fast response and their quality standards to ISO:13485.”
